Sunday, February 14, 2016

Health care and the fiscal cliff

Health care is part of the debate and discussion regarding the fiscal cliff and how the federal government might solve its near and long-term economic problems.

Health care and the fiscal cliff


Health care is part of the debate and discussion regarding the fiscal cliff and how the federal government might solve its near and long-term economic problems.

Wharton Health Care Management Professor Jonathan Kolstad said that while there are health-care issues in resolving the immediate problem of the fiscal cliff, the long-term problem of deciding how the nation pays for health care extends beyond the Nov. 6 election and the Jan. 2 deadline.

“Perhaps you can use the near-term negotiations to look for ways structure future costs, but if you come at it from a budgetary perspective, those are very blunt instruments,” Kolstad said.

Kolstad said that reform of payment systems and the often-conflicting incentives for doctors, hospitals, insurance companies, pharmaceutical companies and patients are the difficult long-term challenges, and unlike other businesses. Everybody wanting more from the system while paying less makes for difficult math.

“Health care is different and hard to model. If you said to people you can have the health-care percentage of GDP from 1965, but you also have to have the health care of 1965, we probably wouldn’t make that trade.”

Peyton Howell, President of AmerisourceBergen Consulting Services, the consulting arm of the Chesterbrook-based pharmaceutical wholesaler, said a failure to pass legislation updating payments to hospitals and pharmacies for drugs will be a problem, along with a payments to physicians.

“Any cut to reimbursements for pharmaceuticals is a particular concern because the rate of reimbursement has not kept up with inflation,” Howell said. “We remain confident that there will be bi-partisan efforts to solve it.”



Staff Writer
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at or 215-854-4506.

David Sell Staff Writer
Also on
letter icon Newsletter